Brokerages expect that Inspire Medical Systems (NASDAQ:INSP) will post earnings per share (EPS) of ($0.36) for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Inspire Medical Systems’ earnings. The lowest EPS estimate is ($0.37) and the highest is ($0.33). The company is expected to issue its next earnings report on Tuesday, November 6th.

On average, analysts expect that Inspire Medical Systems will report full-year earnings of ($4.08) per share for the current fiscal year, with EPS estimates ranging from ($6.18) to ($1.98). For the next fiscal year, analysts forecast that the firm will report earnings of ($1.33) per share, with EPS estimates ranging from ($1.39) to ($1.28). Zacks Investment Research’s EPS averages are an average based on a survey of analysts that cover Inspire Medical Systems.

Inspire Medical Systems (NASDAQ:INSP) last released its quarterly earnings data on Tuesday, August 7th. The company reported ($0.43) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.51) by $0.08. The company had revenue of $10.94 million during the quarter, compared to analysts’ expectations of $9.30 million.

Several research firms have commented on INSP. Zacks Investment Research lowered Inspire Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday. Wells Fargo & Co started coverage on Inspire Medical Systems in a research report on Tuesday, May 29th. They set an “outperform” rating and a $38.00 target price on the stock. Bank of America started coverage on Inspire Medical Systems in a research report on Tuesday, May 29th. They set a “neutral” rating and a $36.00 target price on the stock. Guggenheim started coverage on Inspire Medical Systems in a research report on Tuesday, May 29th. They set a “buy” rating and a $40.00 target price on the stock. Finally, Goldman Sachs Group started coverage on Inspire Medical Systems in a research report on Tuesday, May 29th. They set a “neutral” rating and a $25.00 target price on the stock. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $38.17.

Several large investors have recently made changes to their positions in INSP. BlackRock Inc. purchased a new position in shares of Inspire Medical Systems during the 2nd quarter valued at approximately $19,624,000. FMR LLC purchased a new position in shares of Inspire Medical Systems during the 2nd quarter valued at approximately $11,340,000. Federated Investors Inc. PA purchased a new position in shares of Inspire Medical Systems during the 2nd quarter valued at approximately $10,949,000. Gilder Gagnon Howe & Co. LLC purchased a new position in shares of Inspire Medical Systems during the 2nd quarter valued at approximately $5,010,000. Finally, Massachusetts Financial Services Co. MA purchased a new position in shares of Inspire Medical Systems during the 2nd quarter valued at approximately $4,457,000.

Inspire Medical Systems traded down $0.45, hitting $46.33, during mid-day trading on Tuesday, Marketbeat reports. The company had a trading volume of 147,349 shares, compared to its average volume of 219,383. Inspire Medical Systems has a 12-month low of $22.50 and a 12-month high of $50.00.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Further Reading: Earnings Per Share (EPS) Explained

Get a free copy of the Zacks research report on Inspire Medical Systems (INSP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.